All Stories

  1. Effectiveness of Mycophenolate Mofetil Trough Level Monitoring in Children with Relapsing Nephrotic Syndrome
  2. Addressing the inequity of access to home Dialysis in Europe: recommendations for action informed by an international consensus exercise
  3. Sweeteners: erythritol, xylitol and cardiovascular risk—friend or foe?
  4. Dietary Phosphorus and Metabolic Health in CKD and ESKD
  5. Females with Fabry disease: an expert opinion on diagnosis, clinical management, current challenges and unmet needs
  6. Leadless pacemakers in patients with different stages of chronic kidney disease: Real-world data from the updated i-LEAPER registry
  7. Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: an Italian multicenter prospective study
  8. Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrology
  9. Rationale and Protocol of the ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity—An Italian Study
  10. Vitamin D assay and supplementation: still debatable issues
  11. Post-Kidney Transplant Cancer: A Real-World Retrospective Analysis From a Single Italian Center
  12. Rationale and Protocol of ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity Italian Study
  13. Vitamin D Assay and Supplementation: Still Debatable Issues
  14. How to deal with renal toxicities from immune-based combination treatments in metastatic renal cell carcinoma. A nephrological consultation for Oncologists
  15. Variation in performing kidney biopsy amongst nephrologists in the Asia-Pacific region: A multinational survey
  16. Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers’ perspective
  17. Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices
  18. Assisted PD throughout Europe: advantages, inequities, and solution proposals
  19. Practice of dialysis access interventional nephrology procedures in the Asia‐Pacific region: Getting lay of the land
  20. Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study
  21. Vascular access hands-on training for young nephrologists: The fellows’ experience of the N-PATH project REVAC module
  22. High-Cutoff Hemodialysis Therapy for Patients with Light Chain Cast Nephropathy and AKI Requiring Dialysis: Commentary
  23. Post-mortem renal histopathological findings in 43 COVID-19 patients with acute kidney injury (AKI) deceased in the intensive care unit
  24. A decision-making algorithm proposal for PICCs and midlines insertion in patients with advanced kidney disease: A pilot study
  25. Magnetic Resonance Visibility, Artifacts, and Overall Safety of the Self-Locating Peritoneal Dialysis Catheter with a Tungsten Tip
  26. Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study
  27. α-Gal A missense variants associated with Fabry disease can lead to ER stress and induction of the unfolded protein response
  28. Pathophysiology of AV Fistula Maturation and Non-Maturation
  29. Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus
  30. The multispeciality approach to the management of localised kidney cancer
  31. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes
  32. Availability of assisted peritoneal dialysis in Europe: call for increased and equal access
  33. Influence of peritoneal dialysis catheter type on dislocations and laxative use: a retrospective observational study
  34. Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism
  35. One year of Hybrid Closed Loop on peritoneal dialysis: a case report
  36. Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document
  37. Peritoneal Dialysis for Potential Kidney Transplant Recipients: Pride or Prejudice?
  38. The Role of Vitamin K in CKD-MBD
  39. The Vessels-Bone Axis: Iliac Artery Calcifications, Vertebral Fractures and Vitamin K from VIKI Study
  40. Bone Biopsy for Histomorphometry in Chronic Kidney Disease (CKD): State-of-the-Art and New Perspectives
  41. The IL-8-CXCR1/2 axis contributes to diabetic kidney disease
  42. Ultrasound in central venous access for hemodialysis
  43. Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP)
  44. COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study
  45. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis
  46. Renin-Angiotensin System Blockers and the Risk of COVID-19–Related Mortality in Patients with Kidney Failure
  47. Impact of National Economy and Policies on End-Stage Kidney Care in South Asia and Southeast Asia
  48. Interventional nephrology and vascular access practice: A perspective from South and Southeast Asia
  49. How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group
  50. Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis
  51. Targeting COVID-19 prevention in hemodialysis facilities is associated with a drastic reduction in central venous catheter-related infections
  52. Sevelamer Use, Vitamin K Levels, Vascular Calcifications, and Vertebral Fractures in Hemodialysis Patients: Results from the VIKI Study
  53. Preventive strategies for acute kidney injury in cancer patients
  54. Vitamin K and Osteoporosis
  55. Medical Nutritional Therapy for Patients with Chronic Kidney Disease not on Dialysis: The Low Protein Diet as a Medication
  56. Hemodialysis vascular access affects heart function and outcomes: Tips for choosing the right access for the individual patient
  57. KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer
  58. COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
  59. Multicenter Experience with the Surfacer Inside-Out Access Catheter System in Patients with Thoracic Venous Obstruction: Results from the SAVE Registry
  60. Vitamin K and Kidney Transplantation
  61. Feasibility of routine ultrasound-guided percutaneous transluminal angioplasty in the treatment of native arteriovenous fistula dysfunction
  62. Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis
  63. Plant-based kidney diets prescribed in nutrition clinics: clinical advantages with low risks of hyperkalemia
  64. Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patients
  65. Delivering Safe and Effective Hemodialysis in Patients with Suspected or Confirmed COVID-19 Infection: A Single-Center Perspective from Italy
  66. Clinical relevance of the left brachiocephalic vein anatomy for vascular access in dialysis patients
  67. Charcoal for the management of pruritus and uremic toxins in patients with chronic kidney disease
  68. Vitamin K effects in human health: new insights beyond bone and cardiovascular health
  69. Phosphate and bone fracture risk in chronic kidney disease patients
  70. Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
  71. Dietary Fiber and Gut Microbiota in Renal Diets
  72. Summary of the International Conference on Onco-Nephrology: an emerging field in medicine
  73. Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients
  74. Endorsement and evaluation of dialysis access guidelines from the standpoint of the Vascular Access Society
  75. Update on ANCA-associated vasculitis: from biomarkers to therapy
  76. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
  77. Dietary Fiber and Gut Microbiota in Renal Diets
  78. Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults
  79. Quality assessment of vascular access procedures for hemodialysis: A position paper of the Vascular Access Society based on the analysis of existing guidelines
  80. The adjuvant treatment of kidney cancer: a multidisciplinary outlook
  81. Antiplatelet therapy for prevention of hemodialysis vascular access thrombosis and improving survival
  82. Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus
  83. A Virtual Reality Environment to Visualize Three-Dimensional Patient-Specific Models by a Mobile Head-Mounted Display
  84. Utility of Cardiac Biomarkers in the Setting of Kidney Disease
  85. Patients’ wishes, pregnancy and vascular access: When one size does not fit all
  86. Extracorporeal Removal of Light Chains
  87. Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines
  88. Cigarette Smoking is Associated with Decreased Bone Gla-protein (BGP) Levels in Hemodialysis Patients
  89. Materials and techniques for percutaneous retrieval of intravascular foreign bodies
  90. Urinary Phosphorus Excretion
  91. Editor's Choice – Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
  92. Clinical relevance and future perspective of fractures in patients with chronic kidney disease
  93. Report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access
  94. Authors’ Response to Comments on: The DRIL Procedure for Arteriovenous Access Ischemic Steal: A Controversial Approach
  95. Urinary N-acetyl-β -glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy
  96. Surgical and Endovascular Intervention for Dialysis Access Maturation Failure During and After Arteriovenous Fistula Surgery: Review of the Evidence
  97. Response to: The role of interventional radiology in detecting abnormalities of the superior vena cava anatomy
  98. Acute Kidney Injury in Cancer Patients
  99. OUP accepted manuscript
  100. Response to: The Role of Ultrasound Evaluation in Central Venous Catheter Exchange
  101. Lupus nephritis and B-cell targeting therapy
  102. Vitamin K plasma levels determination in human health
  103. Erratum to: The vascular access in the elderly: a position statement of the Vascular Access Working Group of the Italian Society of Nephrology
  104. Non-Traditional Aspects of Renal Diets: Focus on Fiber, Alkali and Vitamin K1 Intake
  105. Low vitamin K1 intake in haemodialysis patients
  106. Dialysis access: issues related to conversion from peritoneal dialysis to hemodialysis and vice versa
  107. Response to: Central venous catheterization in fragile patients: which is the best approach?
  108. A Survival Benefit With Phosphate-Binder Treatment in CKD Patients Cannot Be Excluded
  109. Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial
  110. Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial
  111. microscopic hematuria in clinical practice, diagnosis at the point of care
  112. Sudden Death in End Stage Renal Disease: Comparing Hemodialysis versus Peritoneal Dialysis
  113. Vitamin K and bone
  114. DASH and Mediterranean Diets as Nutritional Interventions for CKD Patients
  115. Vitamin K Deficiency in Chronic Kidney Disease: Evidence Is Building Up
  116. Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study
  117. Poor early growth and high salt intake in Indian infants
  118. Management of Hyperphosphatemia
  119. The role of monocytes in ANCA-associated vasculitides
  120. Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology
  121. The DRIL procedure for arteriovenous access ischemic steal: a controversial approach
  122. FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of clinical stabilization in Fabry disease
  123. Echo Color Doppler Ultrasound: A Valuable Diagnostic Tool in the Assessment of Arteriovenous Fistula in Hemodialysis Patients
  124. Haemodialysis Plastic Cannulae - a Possible Alternative to Traditional Metal Needles?
  125. Harmonization of Renal Function Assessment Is Needed Throughout the Whole Process of Anticancer Drug Development
  126. Medicaid Coverage and Access to Care for American Indians and Alaska Natives Under the Affordable Care Act
  127. Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease
  128. Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs)
  129. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study
  130. Optimization of Dialysis Catheter Function
  131. Training in Dialysis Access - Charting Future Success
  132. The vascular access in the elderly: a position statement of the Vascular Access Working Group of the Italian Society of Nephrology
  133. Diagnostic and prognostic role of myocardial perfusion scintigraphy in kidney transplant candidates: narrative review
  134. Transplantation of kidneys with tumors
  135. Glomerular diseases and cancer: evaluation of underlying malignancy
  136. Grundlagen der Peritonealdialyse
  137. Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients
  138. Renal toxicity of anticancer agents targeting HER2 and EGFR
  139. Onco-nephrology: a decalogue: Table 1.
  140. Differential Effects of Dabigatran and Warfarin on Bone Volume and Structure in Rats with Normal Renal Function
  141. Renal cancer in kidney transplanted patients
  142. Setting Priorities for Optimizing Vascular Access Decision Making – An International Survey of Patients and Clinicians
  143. Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins
  144. Aneurysms and pseudoaneurysms in dialysis access
  145. Erratum to: Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study
  146. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study
  147. Prevalence of Vertebral Fractures, Vascular Calcifications, and Mortality in Warfarin Treated Hemodialysis Patients
  148. Mortality, sudden death and indication for cardioverter defibrillator implantation in a dialysis population
  149. Tunneled Central Venous Catheter Exchange: Techniques to Improve Prevention of Air Embolism
  150. Renal effects of targeted anticancer therapies
  151. Retro-aortic, left inferior renal capsular vein
  152. Type of peritoneal dialysis catheter and outcomes
  153. Preferred haemodialysis vascular access for diabetic chronic kidney disease patients: a systematic literature review
  154. Congenital anomalies of superior vena cava and their implications in central venous catheterization
  155. Optimizing vascular access in the elderly: words we use affect patient care
  156. Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation
  157. Vitamin K and cardiovascular calcification in CKD: is patient supplementation on the horizon?
  158. Cardiovascular complications of calcium supplementation in chronic kidney disease: are there arrhythmic risks?
  159. Drugs in the elderly with chronic kidney disease: beware of potentially inappropriate medications
  160. Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness
  161. Evaluation of renal function in elderly patients
  162. The nephrologist’s anticoagulation treatment patterns/regimens in chronic hemodialysis patients with atrial fibrillation
  163. The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients
  164. Dialysis central venous catheter types and performance
  165. Fractures in chronic kidney disease: neglected, common, and associated with sickness and death
  166. The Burden of Hypertension and Kidney Disease in Northeast India: The Institute for Indian Mother and Child Noncommunicable Diseases Project
  167. Training and certification in dialysis access
  168. Which cannulation technique for which patient
  169. Reprint of: Vitamin D receptor activation and prevention of arterial ageing
  170. Hypertension and kidney function in an adult population of West Bengal, India: Role of body weight, waist circumference, proteinuria and rural area living
  171. Peritoneal Ultrafiltration in Refractory Heart Failure: A Cohort Study
  172. Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics
  173. Percutaneous ultrasound-guided central venous catheters: the lateral in-plane technique for internal jugular vein access
  174. Phosphate control in dialysis
  175. Left ventricular hypertrophy and serum phosphate in peritoneal dialysis patients
  176. Lethal pulmonary thromboembolism: An autopsy-based study on a rare but legally relevant event
  177. Angiotensin II, distal nephron acidification, acid retention, and possibly increased ammonia levels?
  178. Long-Term Proton Pump Inhibitor Use is Associated with Vascular Calcification in Chronic Kidney Disease: A Cross-Sectional Study Using Propensity Score Analysis
  179. High Prevalence of Vertebral Fractures Assessed by Quantitative Morphometry in Hemodialysis Patients, Strongly Associated with Vascular Calcifications
  180. Vitamin K and bone metabolism in the elderly with normal and reduced kidney function
  181. Inequalities in Transplant Waiting List Activation across Italian Dialysis Centers
  182. Peritoneal dialysis access: open versus laparoscopic surgical techniques
  183. Urinary IgG andα2-Macroglobulin Are Powerful Predictors of Outcome and Responsiveness to Steroids and Cyclophosphamide in Idiopathic Focal Segmental Glomerulosclerosis with Nephrotic Syndrome
  184. Prevention of catheter-related blood stream infections (CRBSI)
  185. Virtual Reality: Emerging Role of Simulation Training in Vascular Access
  186. Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study
  187. Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective study
  188. The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care
  189. Consequences of Vitamin K2 Deficiency in Hemodialysis Patients
  190. Vitamin D receptor activation and prevention of arterial ageing
  191. Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective
  192. Indications for vascular grafts as hemodialysis access: consensus from experience in Italy
  193. Phosphate Control in Peritoneal Dialysis
  194. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy
  195. Neurological complications of hemodialysis: state of the art
  196. Bleeding, Vertebral Fractures and Vascular Calcifications in Patients Treated with Warfarin: Hope for Lower Risks with Alternative Therapies
  197. Sex and Gender Differences in Nephrology
  198. Clinical signifi cance of FGF-23 measurement in dialysis patients
  199. GLOMERULAR MEMBRANOUS NEPHROPATHY AND WERNER SYNDROME: A CASE REPORT
  200. Effects of vitamin K intake on gamma-carboxylated proteins, bone fractures, and vascular calcifications
  201. Treatment with Calcimimetic (Cinacalcet) Alters Epoetin Dosage Requirements in Dialysis Patients: Preliminary Report
  202. High prevalence of hypertension in normal and underweight Indian children
  203. A Complex Renal Cyst: It Is Time to Call the Oncologist?
  204. Central venous catheters: legal issues
  205. Developing recommendations for vascular access for hemodialysis: Vascular Access Working Group of the Italian Society of Nephrology
  206. Does Systematic Preliminar Colour Doppler Study Reduce Kidney Biopsy Complication Incidence?
  207. Regimen Complexity and Prescription Adherence in Dialysis Patients
  208. Vitamin D Receptor Activators and Clinical Outcomes in Chronic Kidney Disease
  209. Plasma Anti-Xa Monitoring for Low-Molecular-Weight Heparins in Patients with Chronic Kidney Disease
  210. Warfarin and heterotopic ossification: good, bad or ugly?
  211. High-Dose Oral Vitamin D Supplementation and Risk of Falls in Older Women
  212. Diagnosis of acute pyelonephritis by contrast-enhanced ultrasonography in kidney transplant patients
  213. Severe hepatic encephalopathy in a patient with liver cirrhosis after administration of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy: a case report
  214. Vertebral fractures in dialysis: Endocrinological disruption of the bone-kidney axis
  215. CCN2 (CTGF) Gene Polymorphism Is a Novel Prognostic Risk Factor for Cardiovascular Outcomes in Hemodialysis Patients
  216. Vascular Calcification and Cardiovascular Outcome in Dialysis Patients: The Role of Gene Polymorphisms
  217. Doppler ultrasound and renal artery stenosis: An overview
  218. Arterial Accelerated Aging in Dialysis Patients: The Clinical Impact of Vascular Calcification
  219. Dialysis Access in Europe and North America: Are We on the Same Path?
  220. Management of Secondary Hyperparathyroidism in the Elderly Patient with Chronic Kidney Disease
  221. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients
  222. Inflammation and vascular calcification in chronic kidney disease: The role of Fetuin-A
  223. Importance of Vitamin D Receptor Activation in Clinical Practice
  224. New Acquisitions in Therapy of Secondary Hyperparathyroidism in Chronic Kidney Disease and Peritoneal Dialysis Patients: Role of Vitamin D Receptor Activators
  225. Substitution of Calcium Carbonate for Aluminum Hydroxide in Patients on Hemodialysis
  226. Renal outcomes in the ONTARGET study
  227. Role of Hyperphosphatemia on Cardiovascular Disease in Dialysis Patients
  228. Vascular Access in Oncology Patients
  229. Vertebral fractures in patients on dialysis: a clinically relevant problem with insufficient investigation
  230. Low-molecular-weight heparins should be used with caution in patients with chronic kidney disease
  231. Calcium and phosphate: serum levels versus body balance
  232. Pathogenesis and Treatment of Secondary Hyperparathyroidism in Dialysis Patients: The Role of Paricalcitol
  233. Successful use of low-dose intravenous paricalcitol in the treatment of severe secondary hyperparathyroidism in a haemodialysis patient
  234. Preventive Measures and New Pharmacological Approaches of Calcium and Phosphate Disorders
  235. Clinical policies on the management of chronic kidney disease patients in Italy
  236. Machiavelli and urinalysis
  237. Gene Polymorphisms and Serum Alpha-2-Heremans-Schmid Levels in Italian Haemodialysis Patients
  238. Serum Fetuin-A Levels Link Inflammation and Cardiovascular Calcification in Hemodialysis Patients
  239. Decreased serum fetuin-A levels after a single haemodialysis session
  240. Phosphate overload accelerates vascular aging in uremic patients
  241. Role of Hyperphosphatemia on Cardiovascular Disease in Dialysis Patients
  242. Calcium and Phosphate Handling in Peritoneal Dialysis
  243. Vascular Calcification in Uremic Conditions: New Insights into Pathogenesis
  244. Matrix GLA Protein Gene Polymorphisms: Clinical Correlates and Cardiovascular Mortality in Chronic Kidney Disease Patients
  245. Pathogenesis of vascular calcification in chronic kidney disease
  246. Work Ability and Health Status in Dialysis Patients
  247. Regression of uraemic pruritus by cyclosporin treatment in a haemodialysis patient
  248. Hyperparathyroidism and Anemia in Uremic Subjects: A Combined Therapeutic Approach
  249. Severe Cortical and Trabecular Osteopenia in Secondary Hyperparathyroidism
  250. Calcium and Phosphate Plasma Levels in Dialysis Patients after Dietary Ca-P Overload
  251. Captopril-Augmented Renal Scanning
  252. Aspiration Pneumonia
  253. Dynamic of β 2 ‐Microglobulin Fibril Formation and Reabsorption: The Role of Proteolysis
  254. Transient decrease of serum bicarbonate levels with Sevelamer hydrochloride as the phosphate binder
  255. Hyperparathyroidism and Anemia in Renal Failure
  256.  -Interferon-Induced Resistance to 1,25-(OH)2 D3 in Human Monocytes and Macrophages: A Mechanism for the Hypercalcemia of Various Granulomatoses
  257. Trace elements in renal failure: are they clinically important?
  258. Treatment of hyperparathyroidism—why is it crucial to control serum phosphate?
  259. Microtubules Mediate Cellular 25-Hydroxyvitamin D3 Trafficking and the Genomic Response to 1,25-Dihydroxyvitamin D3 in Normal Human Monocytes
  260. Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects
  261. Recent advances in intravenous calcitriol treatment
  262. Differential catabolism of 22-oxacalcitriol and 1,25-dihydroxyvitamin D3 by normal human peripheral monocytes.
  263. Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients
  264. Desferrioxamine versus erythropoietin for treatment of dialysis anaemia
  265. OVERT DIALYSIS ENCEPHALOPATHY AND MILDLY RAISED PLASMA ALUMINIUM
  266. DIALYSIS AMYLOIDOSIS WITH MASSIVE POPLITEAL DEPOSITION OF β2-MICROGLOBULIN AMYLOID
  267. Aluminum-Dependent Transfusions in Dialysis
  268. What Every Doctor Should Know about Drug Safety in Patients with Chronic Kidney Disease